Clark County Combined Health District begins administering booster doses of Pfizer COVID-19 vaccine

Clark County Combined Health District begins administering booster doses of Pfizer COVID-19 vaccine

Clark County CombinedHealth District    Charles Patterson,Health Commissioner

529 E. Home Road

Springfield, Ohio 45503

                                                                                                For Immediate Release

                                                                                                September 27, 2021

N E W S

Public Information Office

Nate Smith

937-390-5600 ext. 283

Clark County Combined Health District begins administering booster doses of Pfizer COVID-19 vaccine

CLARK COUNTY — Individuals 65-and-older that became fully vaccinated with the Pfizer-BioNTech/Comirnaty vaccine and are at least six months removed from their second shot are now eligible for a booster dose, and the Clark County Combined Health District (CCCHD) is scheduling appointments for eligible recipients at its COVID-19 Vaccination Center, 110 W. Leffel Lane, Springfield.

The CCCHD Covid-19 Vaccination Center is open from 9 a.m. to 5 p.m. Monday, Wednesday and Friday; and from 1 to 7 p.m. on Tuesday and Thursday. Call (937) 717-2439 to schedule an appointment.

The Centers for Disease Control has approved booster doses for older individuals, as well as for a wider range of individuals with underlying medical conditions and for people who work in “institutional” or “high risk occupational” settings.   

Eligibility for booster doses is currently limited to individuals at the highest risk for severe COVID-19 based upon their age, certain underlying medical conditions, or occupational/institutional settings.

Previously, the U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) for the Pfizer COVID-19 vaccine to allow for use of a single booster dose, to be administered six months or longer after completion of the primary series. In accordance with CDC guidance, those eligible are among highest risk for severe COVID-19, as listed below:

• People 65 years and older and residents in long-term care settings should receive a booster shot of Pfizer COVID-19 vaccine at least six months after their primary Pfizer-BioNTech/Comirnaty series.

• People ages 50 to 64 with certain underlying medical conditions SHOULD receive a booster shot of Pfizer COVID-19 vaccine at least six months after their primary Pfizer-BioNTech/Comirnaty series.

• People ages 18 to 49 who are at high risk for severe COVID-19 due to certain underlying medical conditions may receive a booster shot of Pfizer COVID-19 vaccine at least six months after their primary Pfizer series, based on their individual benefits and risks.

• People ages 18-64 who are at increased risk for COVID-19 exposure and transmission because of occupational or institutional setting may receive a booster shot of Pfizer’s COVID-19 vaccine at least six months after their Pfizer-BioNTech/Comirnaty primary series, based on their individual benefits and risks.

A single booster dose for the Pfizer COVID-19 vaccine may be given six months after completion of a second dose to individuals 65 or older; and to anyone 18-64 with one or more underlying health conditions including: Cancer, asthma, HIV infection, liver disease, high blood pressure, cardiomyopathies or a heart condition.

People 50-64 with one or more of the above conditions SHOULD get a booster shot, according to CDC. Individuals 18-49 with one or more of the above conditions are eligible for a booster dose and may schedule an appointment to receive their booster dose.

Additionally, individuals 18 or older with institutional or workplace exposure to COVID-19 would also qualify for a Pfizer dose six months after their second shot, provided they received Pfizer as their primary series.

Anyone requesting a booster dose of COVID-19 vaccine will be advised of all the qualifying conditions and will self-attest to their own eligibility.

The purpose of this additional dose is to strengthen the immune response when the initial immune response to the primary two-dose vaccine series is likely to be insufficient, according to the CDC’s Advisory Committee on Immunization Practices (ACIP).

Many of the people who are now eligible to receive a booster shot received their initial vaccine early in the vaccination program and will benefit from additional protection. With the Delta variant’s dominance as the circulating strain and cases of COVID-19 increasing significantly across the United States, a booster shot will help strengthen protection against severe disease in those populations who are at high-risk for exposure to COVID-19 or the complications from severe disease.

CDC will continue to monitor the safety and effectiveness of COVID-19 vaccines to ensure appropriate recommendations to keep all Americans safe. CDC will also evaluate with similar urgency available data in the coming weeks to swiftly make additional recommendations for other populations or people who got the Moderna or Johnson & Johnson vaccines.

Individuals that have previously received the Johnson & Johnson COVID-19 vaccine or the Moderna vaccine are not eligible to receive a booster dose at this time.

For more information on CCCHD’s COVID-19 response, visit www.ccchd.com.